Retatrutide 30MG is a 30-milligram format of retatrutide, a synthetic multi receptor agonist peptide investigated as a tri agonist at GLP 1, GIP, and glucagon receptors. Researchers study retatrutide 30MG in the context of metabolic signaling, appetite regulation pathways, and energy balance in preclinical and clinical research settings.

Retatrutide 36MG is a 36-milligram format of retatrutide, a synthetic peptide agonist studied for its activity across multiple metabolic hormone receptor pathways. Researchers investigate retatrutide in preclinical and clinical settings focused on energy balance, glycemic control, and body weight regulation. Its multi-target design makes it a common comparator in studies of incretin and glucagon signaling.

Retatrutide 5MG is a 5-milligram format of retatrutide, a synthetic peptide investigated as a multi incretin receptor agonist. Researchers study Retatrutide 5MG in preclinical and early research settings focused on metabolic signaling, energy balance, and glucose related pathways.

Retatrutide 60MG is a 60-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in metabolic research. Studies have examined retatrutide in the context of GLP 1, GIP, and glucagon receptor signaling, primarily in preclinical and clinical research settings.